Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply

Aliment Pharmacol Ther. 2015 Nov;42(9):1134. doi: 10.1111/apt.13396.

D J Buurman¹, J M Maurer², R J Keizer³, J G W Kosterink^{2

4}, G Dijkstra⁵

¹ Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. d.buurman@umcg.nl.
² Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
³ Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.
⁴ Department of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands.
⁵ Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

No abstract available

Publication types